This federal contract award to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company, is for the delivery of VANCOMYCIN 1 GM VIALS to the Defense Logistics Agency (DLA) Troop Support Medical division, a component of the Department of Defense. The contract, valued at $42,434.98, is structured as a Delivery Order with a Firm Fixed Price pricing type. It has an ultimate completion date of October 28, 2024. The contract does not have a set-aside designation. Fresenius Kabi is a significant supplier of critical care pharmaceuticals to the federal government, particularly the Department of Defense and Department of Veterans Affairs, and holds a $2.24 million Indefinite Delivery Vehicle (IDV) contract with the VA National Acquisition Center for the supply of bortezomib, a cancer treatment drug.
Generated 1/22/25, 9:03 AM